Home » General World News » A biotech company focused on inherited diseases just raised $135 million from a bunch of Wall Street firms

A biotech company focused on inherited diseases just raised $135 million from a bunch of Wall Street firms





Neil Kumar

A biotech focused on developing drugs to treat genetic diseases just raised $135 million.

BridgeBio Pharma, which was founded in 2015, builds out subsidiary companies around different inherited genetic diseases.

The series C round was co-led by investment firms Viking Global Investors and KKR, which were joined by Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital, and Janus Funds.

BridgeBio CEO Neil Kumar told Business Insider that the intention of the company is to fill in a “gap” in funding that can exist for early-stage therapies that haven’t made it to human trials just yet that need read more >>>

Source:: BusinessInsider.Com

Comments are closed.